However, p53 mutations generally occur late in colorectal tumourigenesis, near the transition to malignancy 8,9, suggesting that multiple apoptotic controls including p53 interaction proteins exist to control neoplasia in colorectal carcinomas. The gene discussed is TP53; the disease is colorectal carcinoma.